| Year |
Citation |
Score |
| 2020 |
Gerhart J, Gugerty L, Lecker P, Abdalla F, Martin M, Gerhart O, Gerhart C, Johal K, Bernstein J, Spikes J, Mathers K, Bravo-Nuevo A, George-Weinstein M. Myo/Nog cells are nonprofessional phagocytes. Plos One. 15: e0235898. PMID 32833999 DOI: 10.1371/Journal.Pone.0235898 |
0.384 |
|
| 2020 |
Gerhart J, Bowers J, Gugerty L, Gerhart C, Martin M, Abdalla F, Bravo-Nuevo A, Sullivan JT, Rimkunas R, Albertus A, Casta L, Getts L, Getts R, George-Weinstein M. Brain-specific angiogenesis inhibitor 1 is expressed in the Myo/Nog cell lineage. Plos One. 15: e0234792. PMID 32614850 DOI: 10.1371/Journal.Pone.0234792 |
0.344 |
|
| 2020 |
Gerhart J, Morrison N, Gugerty L, Telander D, Bravo-Nuevo A, George-Weinstein M. Myo/Nog cells expressing muscle proteins are present in preretinal membranes from patients with proliferative vitreoretinopathy. Experimental Eye Research. 197: 108080. PMID 32474138 DOI: 10.1016/J.Exer.2020.108080 |
0.37 |
|
| 2019 |
Gerhart J, Werner L, Mamalis N, Infanti J, Withers C, Abdalla F, Gerhart C, Bravo-Nuevo A, Gerhart O, Getts L, Rhodes K, Bowers J, Getts R, George-Weinstein M. Depletion of Myo/Nog Cells in the Lens Mitigates Posterior Capsule Opacification in Rabbits. Investigative Ophthalmology & Visual Science. 60: 1813-1823. PMID 31042787 DOI: 10.1167/Iovs.19-26713 |
0.338 |
|
| 2019 |
Manley K, Bravo-Nuevo A, Minton AR, Sedano S, Marcy A, Reichman M, Tobia A, Artlett CM, Gilmour SK, Laury-Kleintop LD, Prendergast GC. Preclinical study of the long-range safety and anti-inflammatory effects of high-dose oral meglumine. Journal of Cellular Biochemistry. PMID 30809852 DOI: 10.1002/Jcb.28492 |
0.479 |
|
| 2018 |
Almonte-Baldonado R, Bravo-Nuevo A, Gerald D, Benjamin LE, Prendergast GC, Laury-Kleintop LD. RhoB antibody alters retinal vascularization in models of murine retinopathy. Journal of Cellular Biochemistry. PMID 30536763 DOI: 10.1002/Jcb.28213 |
0.496 |
|
| 2018 |
Swarup A, Bell BA, Du J, Han JYS, Soto J, Abel ED, Bravo-Nuevo A, FitzGerald PG, Peachey NS, Philp NJ. Deletion of GLUT1 in mouse lens epithelium leads to cataract formation. Experimental Eye Research. PMID 29604281 DOI: 10.1016/J.Exer.2018.03.021 |
0.334 |
|
| 2018 |
Gerhart J, Withers C, Gerhart C, Werner L, Mamalis N, Bravo-Nuevo A, Scheinfeld V, FitzGerald P, Getts R, George-Weinstein M. Myo/Nog cells are present in the ciliary processes, on the zonule of Zinn and posterior capsule of the lens following cataract surgery. Experimental Eye Research. PMID 29559302 DOI: 10.1016/J.Exer.2018.03.016 |
0.374 |
|
| 2017 |
Brandli A, Gerhart J, Sutera CK, Purushothuman S, George-Weinstein M, Stone J, Bravo-Nuevo A. Role of Myo/Nog Cells in Neuroprotection: Evidence from the Light Damaged Retina. Plos One. 12: e0169744. PMID 28099524 DOI: 10.1371/Journal.Pone.0169744 |
0.322 |
|
| 2016 |
Mondal A, Smith C, DuHadaway JB, Sutanto-Ward E, Prendergast GC, Bravo-Nuevo A, Muller AJ. IDO1 is an Integral Mediator of Inflammatory Neovascularization. Ebiomedicine. PMID 27889479 DOI: 10.1016/J.Ebiom.2016.11.013 |
0.524 |
|
| 2015 |
Bravo-Nuevo A, Brandli AA, Gerhart J, Nichols J, Pitts M, Sutera CK, Assali S, Scheinfeld V, Prendergast GC, Stone J, George-Weinstein M. Neuroprotective Effect of Myo/Nog Cells in the Stressed Retina. Experimental Eye Research. PMID 26688580 DOI: 10.1016/J.Exer.2015.11.023 |
0.535 |
|
| 2015 |
Mondal A, DuHadaway JB, Sutanto-Ward E, Smith C, Prendergast GC, Bravo-Nuevo A, Muller AJ. Abstract 5223: A novel pro-angiogenic role for IDO1 in inflammatory tumor promotion Cancer Research. 75: 5223-5223. DOI: 10.1158/1538-7445.Am2015-5223 |
0.537 |
|
| 2014 |
Gerhart J, Greenbaum M, Scheinfeld V, Fitzgerald P, Crawford M, Bravo-Nuevo A, Pitts M, George-Weinstein M. Myo/Nog cells: targets for preventing the accumulation of skeletal muscle-like cells in the human lens. Plos One. 9: e95262. PMID 24736495 DOI: 10.1371/Journal.Pone.0095262 |
0.385 |
|
| 2014 |
Bravo-Nuevo A, Marcy A, Huang M, Kappler F, Mulgrew J, Laury-Kleintop L, Reichman M, Tobia A, Prendergast GC. Meglumine exerts protective effects against features of metabolic syndrome and type II diabetes. Plos One. 9: e90031. PMID 24587200 DOI: 10.1371/Journal.Pone.0090031 |
0.493 |
|
| 2013 |
Kazerounian S, Gerald D, Huang M, Chin YR, Udayakumar D, Zheng N, O'Donnell RK, Perruzzi C, Mangiante L, Pourat J, Phung TL, Bravo-Nuevo A, Shechter S, McNamara S, Duhadaway JB, et al. RhoB differentially controls Akt function in tumor cells and stromal endothelial cells during breast tumorigenesis. Cancer Research. 73: 50-61. PMID 23135917 DOI: 10.1158/0008-5472.Can-11-3055 |
0.493 |
|
| 2011 |
Bravo-Nuevo A, Sugimoto H, Iyer S, Fallon Z, Lucas JM, Kazerounian S, Prendergast GC, Kalluri R, Shapiro NI, Benjamin LE. RhoB loss prevents streptozotocin-induced diabetes and ameliorates diabetic complications in mice. The American Journal of Pathology. 178: 245-52. PMID 21224061 DOI: 10.1016/J.Ajpath.2010.11.040 |
0.489 |
|
| 2004 |
Walsh N, Bravo-Nuevo A, Geller S, Stone J. Resistance of photoreceptors in the C57BL/6-c2J, C57BL/6J, and BALB/cJ mouse strains to oxygen stress: evidence of an oxygen phenotype. Current Eye Research. 29: 441-7. PMID 15764088 DOI: 10.1080/02713680490522416 |
0.306 |
|
| 2004 |
Bravo-Nuevo A, Walsh N, Stone J. Photoreceptor degeneration and loss of retinal function in the C57BL/6-C2J mouse. Investigative Ophthalmology & Visual Science. 45: 2005-12. PMID 15161869 DOI: 10.1167/Iovs.03-0842 |
0.346 |
|
| Show low-probability matches. |